tradingkey.logo
搜尋

China SXT Pharmaceuticals Inc

SXTC
添加自選
0.061USD
-0.012-16.42%
收盤 07-31 16:00美東報價延遲15分鐘
58.54K總市值
虧損本益比TTM

關於 China SXT Pharmaceuticals Inc 公司

China SXT Pharmaceuticals Inc is a holding company principally engaged in the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). TCMP is a type of Chinese Traditional Medicine (TCM) products. The Company sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The Company sells its products under the brand Suxuantang. The Company mainly operates its businesses in the domestic market.

China SXT Pharmaceuticals Inc簡介

公司代碼SXTC
公司名稱China SXT Pharmaceuticals Inc
上市日期Jan 04, 2019
CEOBeng (Lim Sze)
員工數量75
證券類型Ordinary Share
年結日Jan 04
公司地址178 Taidong Road North
城市TAIZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
國家China
郵編225300
電話8652386298290
網址https://www.sxtchina.com/
公司代碼SXTC
上市日期Jan 04, 2019
CEOBeng (Lim Sze)

China SXT Pharmaceuticals Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
-100.00%
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--
Mr. Lim Sze (Simon) Beng
Mr. Lim Sze (Simon) Beng
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
-100.00%
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--

常見問題

China SXT Pharmaceuticals Inc的前五大股東是誰?

China SXT Pharmaceuticals Inc的前五大股東如下:Mr. Feng Zhou

有多少機構持有China SXT Pharmaceuticals Inc(SXTC)的股份?

截至2026Q1,共有18家機構持有China SXT Pharmaceuticals Inc的股份,合計持有的股份價值約為2.18K,占公司總股份的0.03% 。與2025Q4相比,機構持股有所增加,增幅為69.00。

哪個業務部門對China SXT Pharmaceuticals Inc的收入貢獻最大?

在2026Q1,Regular TCMP業務部門對China SXT Pharmaceuticals Inc的收入貢獻最大,創收1.44M,占總收入的82.86% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有